{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:35:12Z","timestamp":1792798512430,"version":"4.5.0"},"reference-count":240,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12602-025-10807-9","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:53:55Z","timestamp":1761130435000},"page":"3781-3807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Modulation of Innate Immunity by Short-Chain Fatty Acids in Probiotic and Fecal Microbiota Transplantation Therapies for the Treatment of Colon Disorders"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8811-448X","authenticated-orcid":false,"given":"Jayasree","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-7962","authenticated-orcid":false,"given":"Ritobrata","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"10807_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2013.11.008","volume":"68","author":"I Koboziev","year":"2014","unstructured":"Koboziev I, Webb CR, Furr KL, Grisham MB (2014) Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med 68:122\u2013133. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.11.008","journal-title":"Free Radic Biol Med"},{"key":"10807_CR2","doi-asserted-by":"publisher","DOI":"10.1264\/jsme2.me17017","volume":"32","author":"ET Hillman","year":"2017","unstructured":"Hillman ET, Lu H, Yao T, Nakatsu CH (2017) Microbial ecology along the gastrointestinal tract. Microbes Environ 32:ME17017. https:\/\/doi.org\/10.1264\/jsme2.me17017","journal-title":"Microbes Environ"},{"key":"10807_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu Z-X, Chen X-Y et al (2022) Microbiota in health and diseases. Signal Transduct Target Ther 7:135. https:\/\/doi.org\/10.1038\/s41392-022-00974-4","journal-title":"Signal Transduct Target Ther"},{"key":"10807_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221091524","volume":"15","author":"G Ianiro","year":"2022","unstructured":"Ianiro G, Iorio A, Porcari S et al (2022) How the gut parasitome affects human health. Ther Adv Gastroenterol 15:17562848221091524. https:\/\/doi.org\/10.1177\/17562848221091524","journal-title":"Ther Adv Gastroenterol"},{"key":"10807_CR5","doi-asserted-by":"publisher","first-page":"1035S","DOI":"10.1093\/ajcn\/69.5.1035s","volume":"69","author":"RI Mackie","year":"1999","unstructured":"Mackie RI, Sghir A, Gaskins HR (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69:1035S-1045S. https:\/\/doi.org\/10.1093\/ajcn\/69.5.1035s","journal-title":"Am J Clin Nutr"},{"key":"10807_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/00365521.1997.11720708","volume":"32","author":"GT Macfarlane","year":"1997","unstructured":"Macfarlane GT, Macfarlane S (1997) Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol 32:3\u20139. https:\/\/doi.org\/10.1080\/00365521.1997.11720708","journal-title":"Scand J Gastroenterol"},{"key":"10807_CR7","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, Amand ALSt, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci 104:13780\u201313785. https:\/\/doi.org\/10.1073\/pnas.0706625104","journal-title":"Proc Natl Acad Sci"},{"key":"10807_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492\u2013506. https:\/\/doi.org\/10.1038\/s41422-020-0332-7","journal-title":"Cell Res"},{"key":"10807_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.10.1221","volume":"28","author":"JH Cummings","year":"1987","unstructured":"Cummings JH, Pomare EW, Branch WJ (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221. https:\/\/doi.org\/10.1136\/gut.28.10.1221","journal-title":"Gut"},{"key":"10807_CR10","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.r036012","volume":"54","author":"G Besten","year":"2013","unstructured":"Besten G, Eunen K, Groen AK et al (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325\u20132340. https:\/\/doi.org\/10.1194\/jlr.r036012","journal-title":"J Lipid Res"},{"key":"10807_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00869-5","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang H, Chen T (2022) Regulatory role of short-chain fatty acids in inflammatory bowel disease. Cell Commun Signal 20:64. https:\/\/doi.org\/10.1186\/s12964-022-00869-5","journal-title":"Cell Commun Signal"},{"key":"10807_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108273","volume":"239","author":"T Ikeda","year":"2022","unstructured":"Ikeda T, Nishida A, Yamano M, Kimura I (2022) Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases. Pharmacol Ther 239:108273. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108273","journal-title":"Pharmacol Ther"},{"key":"10807_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114763","volume":"163","author":"F Golpour","year":"2023","unstructured":"Golpour F, Abbasi-Alaei M, Babaei F et al (2023) Short chain fatty acids, a possible treatment option for autoimmune diseases. Biomed Pharmacother 163:114763. https:\/\/doi.org\/10.1016\/j.biopha.2023.114763","journal-title":"Biomed Pharmacother"},{"key":"10807_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/annrheumdis-2021-221386","volume":"81","author":"K Martinsson","year":"2022","unstructured":"Martinsson K, D\u00fcrholz K, Schett G et al (2022) Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA. Ann Rheum Dis 81:445\u2013447. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221386","journal-title":"Ann Rheum Dis"},{"key":"10807_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01219-9","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian Y-P, Zhang Y-N (2023) Short-chain fatty acids in diseases. Cell Commun Signal 21:212. https:\/\/doi.org\/10.1186\/s12964-023-01219-9","journal-title":"Cell Commun Signal"},{"key":"10807_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/apt.14689","volume":"48","author":"PA Gill","year":"2018","unstructured":"Gill PA, Zelm MC, Muir JG, Gibson PR (2018) Review article: Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment Pharmacol Ther 48:15\u201334. https:\/\/doi.org\/10.1111\/apt.14689","journal-title":"Aliment Pharmacol Ther"},{"key":"10807_CR17","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.3748\/wjg.v26.i30.4378","volume":"26","author":"B Yue","year":"2020","unstructured":"Yue B, Yu Z-L, Lv C et al (2020) Regulation of the intestinal microbiota: an emerging therapeutic strategy for inflammatory bowel disease. World J Gastroenterol 26:4378\u20134393. https:\/\/doi.org\/10.3748\/wjg.v26.i30.4378","journal-title":"World J Gastroenterol"},{"key":"10807_CR18","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1080\/19490976.2020.1764309","volume":"11","author":"K Ka\u017amierczak-Siedlecka","year":"2020","unstructured":"Ka\u017amierczak-Siedlecka K, Daca A, Fic M et al (2020) Therapeutic methods of gut microbiota modification in colorectal cancer management \u2013 fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes 11:1518\u20131530. https:\/\/doi.org\/10.1080\/19490976.2020.1764309","journal-title":"Gut Microbes"},{"key":"10807_CR19","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1001\/jama.2012.3507","volume":"307","author":"S Hempel","year":"2012","unstructured":"Hempel S, Newberry SJ, Maher AR et al (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307:1959\u20131969. https:\/\/doi.org\/10.1001\/jama.2012.3507","journal-title":"JAMA"},{"key":"10807_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1389557523666230608163823","volume":"24","author":"S Zaib","year":"2024","unstructured":"Zaib S, Hayat A, Khan I (2024) Probiotics and their beneficial health effects. Mini-Rev Med Chem 24:110\u2013125. https:\/\/doi.org\/10.2174\/1389557523666230608163823","journal-title":"Mini-Rev Med Chem"},{"key":"10807_CR21","first-page":"854","volume":"44","author":"B Eiseman","year":"1958","unstructured":"Eiseman B, Silen W, Bascom GS, Kauvar AJ (1958) Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44:854\u2013859","journal-title":"Surgery"},{"key":"10807_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.chom.2023.03.020","volume":"31","author":"S Porcari","year":"2023","unstructured":"Porcari S, Benech N, Valles-Colomer M et al (2023) Key determinants of success in fecal microbiota transplantation: from microbiome to clinic. Cell Host Microbe 31:712\u2013733. https:\/\/doi.org\/10.1016\/j.chom.2023.03.020","journal-title":"Cell Host Microbe"},{"key":"10807_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5740\/jaoacint.sge_macfarlane","volume":"95","author":"GT Macfarlane","year":"2012","unstructured":"Macfarlane GT, Macfarlane S (2012) Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 95:50\u201360. https:\/\/doi.org\/10.5740\/jaoacint.sge_macfarlane","journal-title":"J AOAC Int"},{"key":"10807_CR24","doi-asserted-by":"publisher","first-page":"10347","DOI":"10.1016\/s0021-9258(18)81625-8","volume":"264","author":"F Leighton","year":"1989","unstructured":"Leighton F, Bergseth S, R\u00f8rtveit T (1989) Free acetate production by rat hepatocytes during peroxisomal fatty acid and dicarboxylic acid oxidation. J Biol Chem 264:10347\u201310350. https:\/\/doi.org\/10.1016\/s0021-9258(18)81625-8","journal-title":"J Biol Chem"},{"key":"10807_CR25","first-page":"354","volume":"108","author":"E Hijova","year":"2007","unstructured":"Hijova E, Chmelarova A (2007) Short chain fatty acids and colonic health. Bratisl L\u00e9k List 108:354\u2013358","journal-title":"Bratisl L\u00e9k List"},{"key":"10807_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4611","volume":"5","author":"G Frost","year":"2014","unstructured":"Frost G, Sleeth ML, Sahuri-Arisoylu M et al (2014) The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 5:3611. https:\/\/doi.org\/10.1038\/ncomms4611","journal-title":"Nat Commun"},{"key":"10807_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","volume":"156","author":"F De Vadder","year":"2014","unstructured":"De Vadder F, Kovatcheva-Datchary P, Goncalves D et al (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84\u201396. https:\/\/doi.org\/10.1016\/j.cell.2013.12.016","journal-title":"Cell"},{"key":"10807_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","volume":"29","author":"B van der Hee","year":"2021","unstructured":"van der Hee B, Wells JM (2021) Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol 29:700\u2013712. https:\/\/doi.org\/10.1016\/j.tim.2021.02.001","journal-title":"Trends Microbiol"},{"key":"10807_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s1388-1981(01)00117-2","volume":"1532","author":"H Yamashita","year":"2001","unstructured":"Yamashita H, Kaneyuki T, Tagawa K (2001) Production of acetate in the liver and its utilization in peripheral tissues. Biochimica et Biophysica Acta (BBA) 1532:79\u201387. https:\/\/doi.org\/10.1016\/s1388-1981(01)00117-2","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"10807_CR30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/s0016-5085(19)30508-6","volume":"78","author":"H Ruppin","year":"1980","unstructured":"Ruppin H, Bar-Meir S, Soergel KH (1980) Absorption of short-chain fatty acids by the colon. Gastroenterology 78:1500\u20131507. https:\/\/doi.org\/10.1016\/s0016-5085(19)30508-6","journal-title":"Gastroenterology"},{"key":"10807_CR31","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala SM, Talukdar R, Subramanyam C et al (2015) Role of the normal gut microbiota. World J Gastroenterol 21:8787\u20138803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787","journal-title":"World J Gastroenterol"},{"key":"10807_CR32","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/s41396-021-00937-7","volume":"15","author":"N Tsukuda","year":"2021","unstructured":"Tsukuda N, Yahagi K, Hara T et al (2021) Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life. ISME J 15:2574\u20132590. https:\/\/doi.org\/10.1038\/s41396-021-00937-7","journal-title":"ISME J"},{"key":"10807_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fevo.2019.00153","volume":"7","author":"NW Smith","year":"2019","unstructured":"Smith NW, Shorten PR, Altermann E (2019) The classification and evolution of bacterial cross-feeding. Front Ecol Evol 7:153. https:\/\/doi.org\/10.3389\/fevo.2019.00153","journal-title":"Front Ecol Evol"},{"key":"10807_CR34","doi-asserted-by":"publisher","first-page":"17941","DOI":"10.1073\/pnas.1412673111","volume":"111","author":"NM Oliveira","year":"2014","unstructured":"Oliveira NM, Niehus R, Foster KR (2014) Evolutionary limits to cooperation in microbial communities. Proc Natl Acad Sci U S A 111:17941\u201317946. https:\/\/doi.org\/10.1073\/pnas.1412673111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10807_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.780469","volume":"12","author":"V Mataigne","year":"2021","unstructured":"Mataigne V, Vannier N, Vandenkoornhuyse P, Hacquard S (2021) Microbial systems ecology to understand cross-feeding in microbiomes. Front Microbiol 12:780469. https:\/\/doi.org\/10.3389\/fmicb.2021.780469","journal-title":"Front Microbiol"},{"key":"10807_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00770-17","volume":"8","author":"C Belzer","year":"2017","unstructured":"Belzer C, Chia LW, Aalvink S et al (2017) Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. mBio 8:e00770-17. https:\/\/doi.org\/10.1128\/mbio.00770-17","journal-title":"mBio"},{"key":"10807_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42112-w","volume":"14","author":"VR Marcelino","year":"2023","unstructured":"Marcelino VR, Welsh C, Diener C (2023) Disease-specific loss of microbial cross-feeding interactions in the human gut. Nat Commun 14:6546. https:\/\/doi.org\/10.1038\/s41467-023-42112-w","journal-title":"Nat Commun"},{"key":"10807_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/bf01536766","volume":"35","author":"JA Flick","year":"1990","unstructured":"Flick JA, Hamilton SR, Rosales FJ, Perman JA (1990) Methane excretion and experimental colonic carcinogenesis. Dig Dis Sci 35:221\u2013224. https:\/\/doi.org\/10.1007\/bf01536766","journal-title":"Dig Dis Sci"},{"key":"10807_CR39","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1128\/aem.01296-06","volume":"72","author":"G Falony","year":"2006","unstructured":"Falony G, Vlachou A, Verbrugghe K, Vuyst LD (2006) Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72:7835\u20137841. https:\/\/doi.org\/10.1128\/aem.01296-06","journal-title":"Appl Environ Microbiol"},{"key":"10807_CR40","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1128\/aem.72.5.3593-3599.2006","volume":"72","author":"A Belenguer","year":"2006","unstructured":"Belenguer A, Duncan SH, Calder AG et al (2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72:3593\u20133599. https:\/\/doi.org\/10.1128\/aem.72.5.3593-3599.2006","journal-title":"Appl Environ Microbiol"},{"key":"10807_CR41","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/s0006-291x(03)00488-1","volume":"303","author":"NE Nilsson","year":"2003","unstructured":"Nilsson NE, Kotarsky K, Owman C, Olde B (2003) Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303:1047\u20131052. https:\/\/doi.org\/10.1016\/s0006-291x(03)00488-1","journal-title":"Biochem Biophys Res Commun"},{"key":"10807_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/164_2016_52","volume":"236","author":"IG Tikhonova","year":"2016","unstructured":"Tikhonova IG (2016) Free fatty acid receptors. Handb Exp Pharmacol 236:57\u201377. https:\/\/doi.org\/10.1007\/164_2016_52","journal-title":"Handb Exp Pharmacol"},{"key":"10807_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj2384","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang X, Guseinov A-A, Jenkins L (2024) Structural basis for the ligand recognition and signaling of free fatty acid receptors. Sci Adv 10:eadj2384. https:\/\/doi.org\/10.1126\/sciadv.adj2384","journal-title":"Sci Adv"},{"key":"10807_CR44","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.m211609200","volume":"278","author":"AJ Brown","year":"2003","unstructured":"Brown AJ, Goldsworthy SM, Barnes AA et al (2003) The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids*. J Biol Chem 278:11312\u201311319. https:\/\/doi.org\/10.1074\/jbc.m211609200","journal-title":"J Biol Chem"},{"key":"10807_CR45","doi-asserted-by":"publisher","first-page":"25481","DOI":"10.1074\/jbc.m301403200","volume":"278","author":"EL Poul","year":"2003","unstructured":"Poul EL, Loison C, Struyf S et al (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation*. J Biol Chem 278:25481\u201325489. https:\/\/doi.org\/10.1074\/jbc.m301403200","journal-title":"J Biol Chem"},{"key":"10807_CR46","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","volume":"85","author":"N Wettschureck","year":"2005","unstructured":"Wettschureck N, Offermanns S (2005) Mammalian G proteins and their cell type specific functions. Physiol Rev 85:1159\u20131204. https:\/\/doi.org\/10.1152\/physrev.00003.2005","journal-title":"Physiol Rev"},{"key":"10807_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.568991","volume":"7","author":"M Shackley","year":"2020","unstructured":"Shackley M, Ma Y, Tate EW (2020) Short chain fatty acids enhance expression and activity of the umami taste receptor in enteroendocrine cells via a G\u03b1i\/o pathway. Front Nutr 7:568991. https:\/\/doi.org\/10.3389\/fnut.2020.568991","journal-title":"Front Nutr"},{"key":"10807_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8060154","volume":"8","author":"SP Mishra","year":"2020","unstructured":"Mishra SP, Karunakar P, Taraphder S, Yadav H (2020) Free fatty acid receptors 2 and 3 as microbial metabolite sensors to shape host health: pharmacophysiological view. Biomedicines 8:154. https:\/\/doi.org\/10.3390\/biomedicines8060154","journal-title":"Biomedicines"},{"key":"10807_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep34145","volume":"6","author":"Z Ang","year":"2016","unstructured":"Ang Z, Er JZ, Tan NS et al (2016) Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2\/FFAR3 short-chain fatty acid receptor agonists. Sci Rep 6:34145. https:\/\/doi.org\/10.1038\/srep34145","journal-title":"Sci Rep"},{"key":"10807_CR50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1096\/fj.201700252rr","volume":"32","author":"Z Ang","year":"2018","unstructured":"Ang Z, Xiong D, Wu M, Ding JL (2018) FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing. FASEB J 32:289\u2013303. https:\/\/doi.org\/10.1096\/fj.201700252rr","journal-title":"FASEB J"},{"key":"10807_CR51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.14348\/molcells.2021.0021","volume":"44","author":"B-O Park","year":"2021","unstructured":"Park B-O, Kim SH, Kim JH et al (2021) The short-chain fatty acid receptor GPR43 modulates YAP\/TAZ via RhoA. Mol Cells 44:458\u2013467. https:\/\/doi.org\/10.14348\/molcells.2021.0021","journal-title":"Mol Cells"},{"key":"10807_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179696","volume":"12","author":"A Nakajima","year":"2017","unstructured":"Nakajima A, Nakatani A, Hasegawa S et al (2017) The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages. PLoS ONE 12:e0179696. https:\/\/doi.org\/10.1371\/journal.pone.0179696","journal-title":"PLoS ONE"},{"key":"10807_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxab028","volume":"207","author":"C Huang","year":"2021","unstructured":"Huang C, Du W, Ni Y et al (2021) The effect of short chain fatty acids on M2 macrophages polarization in vitro and in vivo. Clin Exp Immunol 207:uxab028. https:\/\/doi.org\/10.1093\/cei\/uxab028","journal-title":"Clin Exp Immunol"},{"key":"10807_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00441-005-0140-x","volume":"324","author":"S Karaki","year":"2006","unstructured":"Karaki S, Mitsui R, Hayashi H (2006) Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 324:353\u2013360. https:\/\/doi.org\/10.1007\/s00441-005-0140-x","journal-title":"Cell Tissue Res"},{"key":"10807_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2206507","volume":"15","author":"T Ito","year":"2023","unstructured":"Ito T, Nakanishi Y, Shibata R et al (2023) The propionate-GPR41 axis in infancy protects from subsequent bronchial asthma onset. Gut Microbes 15:2206507. https:\/\/doi.org\/10.1080\/19490976.2023.2206507","journal-title":"Gut Microbes"},{"key":"10807_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","volume":"145","author":"MH Kim","year":"2013","unstructured":"Kim MH, Kang SG, Park JH et al (2013) Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145:396-406.e10. https:\/\/doi.org\/10.1053\/j.gastro.2013.04.056","journal-title":"Gastroenterology"},{"key":"10807_CR57","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/mi.2016.114","volume":"10","author":"W Wu","year":"2017","unstructured":"Wu W, Sun M, Chen F et al (2017) Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol 10:946\u2013956. https:\/\/doi.org\/10.1038\/mi.2016.114","journal-title":"Mucosal Immunol"},{"key":"10807_CR58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10735-007-9145-y","volume":"39","author":"S Karaki","year":"2008","unstructured":"Karaki S, Tazoe H, Hayashi H et al (2008) Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 39:135\u2013142. https:\/\/doi.org\/10.1007\/s10735-007-9145-y","journal-title":"J Mol Histol"},{"key":"10807_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01802","volume":"10","author":"AJ Forgie","year":"2019","unstructured":"Forgie AJ, Fouhse JM, Willing BP (2019) Diet-microbe-host interactions that affect gut mucosal integrity and infection resistance. Front Immunol 10:1802. https:\/\/doi.org\/10.3389\/fimmu.2019.01802","journal-title":"Front Immunol"},{"key":"10807_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.667066","volume":"12","author":"JE Martinez","year":"2021","unstructured":"Martinez JE, Kahana DD, Ghuman S et al (2021) Unhealthy lifestyle and gut dysbiosis: a better understanding of the effects of poor diet and nicotine on the intestinal microbiome. Front Endocrinol 12:667066. https:\/\/doi.org\/10.3389\/fendo.2021.667066","journal-title":"Front Endocrinol"},{"key":"10807_CR61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2022.01.009","volume":"55","author":"TL Frankel","year":"2022","unstructured":"Frankel TL, di Magliano MP (2022) Immune sensing of microbial metabolites: action at the tumor. Immunity 55:192\u2013194. https:\/\/doi.org\/10.1016\/j.immuni.2022.01.009","journal-title":"Immunity"},{"key":"10807_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12929-018-0483-8","volume":"25","author":"LC-H Yu","year":"2018","unstructured":"Yu LC-H (2018) Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci 25:79. https:\/\/doi.org\/10.1186\/s12929-018-0483-8","journal-title":"J Biomed Sci"},{"key":"10807_CR63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00384-004-0639-8","volume":"20","author":"HSP Souza","year":"2005","unstructured":"Souza HSP, Tortori CJA, Castelo-Branco MTL et al (2005) Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways. Int J Colorectal Dis 20:277\u2013286. https:\/\/doi.org\/10.1007\/s00384-004-0639-8","journal-title":"Int J Colorectal Dis"},{"key":"10807_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.17","volume":"5","author":"R Corr\u00eaa-Oliveira","year":"2016","unstructured":"Corr\u00eaa-Oliveira R, Fachi JL, Vieira A et al (2016) Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol 5:e73. https:\/\/doi.org\/10.1038\/cti.2016.17","journal-title":"Clin Transl Immunol"},{"key":"10807_CR65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH (2023) Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol 20:341\u2013350. https:\/\/doi.org\/10.1038\/s41423-023-00987-1","journal-title":"Cell Mol Immunol"},{"key":"10807_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1128\/cmr.15.1.79-94.2002","volume":"15","author":"BA Hendrickson","year":"2002","unstructured":"Hendrickson BA, Gokhale R, Cho JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15:79\u201394. https:\/\/doi.org\/10.1128\/cmr.15.1.79-94.2002","journal-title":"Clin Microbiol Rev"},{"key":"10807_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Berre CL et al (2020) Ulcerative colitis. Nat Rev Dis Primers 6:74. https:\/\/doi.org\/10.1038\/s41572-020-0205-x","journal-title":"Nat Rev Dis Primers"},{"key":"10807_CR68","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7861\/clinmed.2023-0493","volume":"23","author":"E Cockburn","year":"2023","unstructured":"Cockburn E, Kamal S, Chan A (2023) Crohn\u2019s disease: an update. Clin Med 23:549\u2013557. https:\/\/doi.org\/10.7861\/clinmed.2023-0493","journal-title":"Clin Med"},{"key":"10807_CR69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cgh.2019.07.005","volume":"18","author":"CL Berre","year":"2020","unstructured":"Berre CL, Ananthakrishnan AN, Danese S et al (2020) Ulcerative colitis and Crohn\u2019s disease have similar burden and goals for treatment. Clin Gastroenterol Hepatol 18:14\u201323. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10807_CR70","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/nejmra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT (2020) Pathophysiology of inflammatory bowel diseases. N Engl J Med 383:2652\u20132664. https:\/\/doi.org\/10.1056\/nejmra2002697","journal-title":"N Engl J Med"},{"key":"10807_CR71","doi-asserted-by":"publisher","first-page":"S557","DOI":"10.1093\/ecco-jcc\/jjx180.998","volume":"12","author":"J Inoue","year":"2018","unstructured":"Inoue J, Sasaki K, Hoshi N et al (2018) P871 Successful detection of dysbiosis and altered short-chain-fatty acids levels in in vitro colonic microbiota culture system using faecal samples of ulcerative colitis. J Crohns Colitis 12:S557\u2013S558. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx180.998","journal-title":"J Crohns Colitis"},{"key":"10807_CR72","doi-asserted-by":"publisher","first-page":"S552","DOI":"10.1093\/ecco-jcc\/jjx180.988","volume":"12","author":"N Danilova","year":"2018","unstructured":"Danilova N, Abdulkhakov S, Grigoryeva T et al (2018) P861 short-chain fatty acids as a marker of intestinal dysbiosis in patients with inflammatory bowel diseases. J Crohns Colitis 12:S552\u2013S552. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx180.988","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10807_CR73","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ecco-jcc\/jjx137","volume":"12","author":"EJ Laserna-Mendieta","year":"2018","unstructured":"Laserna-Mendieta EJ, Clooney AG, Carretero-Gomez JF et al (2018) Determinants of reduced genetic capacity for butyrate synthesis by the gut microbiome in Crohn\u2019s disease and ulcerative colitis. J Crohns Colitis 12(2):204\u2013216. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx137","journal-title":"J Crohns Colitis"},{"key":"10807_CR74","doi-asserted-by":"publisher","first-page":"S311","DOI":"10.1093\/ecco-jcc\/jjz203.444","volume":"14","author":"L Oliveira","year":"2020","unstructured":"Oliveira L, Sassaki LY, Quagli AEV, de Barros JR (2020) P315 short-chain fatty acid profile in inflammatory bowel disease. J Crohns Colitis 14:S311\u2013S312. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz203.444","journal-title":"J Crohns Colitis"},{"key":"10807_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad212.0166","volume":"18","author":"Q Mao","year":"2024","unstructured":"Mao Q, Zhang W, Zhang Y et al (2024) P036 microbiota metabolite butyrate attenuates intestinal inflammation through autophagy activation. J Crohns Colitis 18:i294\u2013i295. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad212.0166","journal-title":"J Crohns Colitis"},{"key":"10807_CR76","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","volume":"138","author":"MS Pino","year":"2010","unstructured":"Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterology 138:2059\u20132072. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.065","journal-title":"Gastroenterology"},{"key":"10807_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15279-9","volume":"11","author":"WHM Hoevenaar","year":"2020","unstructured":"Hoevenaar WHM, Janssen A, Quirindongo AI et al (2020) Degree and site of chromosomal instability define its oncogenic potential. Nat Commun 11:1501. https:\/\/doi.org\/10.1038\/s41467-020-15279-9","journal-title":"Nat Commun"},{"key":"10807_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","volume":"15","author":"CL Sears","year":"2014","unstructured":"Sears CL, Garrett WS (2014) Microbes, microbiota, and colon cancer. Cell Host Microbe 15:317\u2013328. https:\/\/doi.org\/10.1016\/j.chom.2014.02.007","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10807_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09054-2","volume":"21","author":"M Rebersek","year":"2021","unstructured":"Rebersek M (2021) Gut microbiome and its role in colorectal cancer. BMC Cancer 21(1):1325. https:\/\/doi.org\/10.1186\/s12885-021-09054-2","journal-title":"BMC Cancer"},{"key":"10807_CR80","doi-asserted-by":"publisher","unstructured":"Alvandi E, Wong WKM, Joglekar MV, et al (2022) Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis. medRxiv 2022.03.13.22272319. https:\/\/doi.org\/10.1101\/2022.03.13.22272319","DOI":"10.1101\/2022.03.13.22272319"},{"key":"10807_CR81","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/jn\/132.5.1012","volume":"132","author":"BF Hinnebusch","year":"2002","unstructured":"Hinnebusch BF, Meng S, Wu JT et al (2002) The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132:1012\u20131017. https:\/\/doi.org\/10.1093\/jn\/132.5.1012","journal-title":"J Nutr"},{"key":"10807_CR82","doi-asserted-by":"publisher","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485s","volume":"133","author":"JR Davie","year":"2003","unstructured":"Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133:2485S-2493S. https:\/\/doi.org\/10.1093\/jn\/133.7.2485s","journal-title":"J Nutr"},{"key":"10807_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190810","volume":"14","author":"C Mowat","year":"2023","unstructured":"Mowat C, Dhatt J, Bhatti I (2023) Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity. Front Immunol 14:1190810. https:\/\/doi.org\/10.3389\/fimmu.2023.1190810","journal-title":"Front Immunol"},{"key":"10807_CR84","doi-asserted-by":"publisher","first-page":"27280","DOI":"10.18632\/oncotarget.25546","volume":"9","author":"A Han","year":"2018","unstructured":"Han A, Bennett N, Ahmed B et al (2018) Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases. Oncotarget 9:27280\u201327292. https:\/\/doi.org\/10.18632\/oncotarget.25546","journal-title":"Oncotarget"},{"key":"10807_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pbj.2016.04.004","volume":"1","author":"P Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves P, Martel F (2016) Regulation of colonic epithelial butyrate transport: focus on colorectal cancer. Porto Biomed J 1:83\u201391. https:\/\/doi.org\/10.1016\/j.pbj.2016.04.004","journal-title":"Porto Biomed J"},{"key":"10807_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114483","volume":"186","author":"NH Moniri","year":"2021","unstructured":"Moniri NH, Farah Q (2021) Short-chain free-fatty acid G protein-coupled receptors in colon cancer. Biochem Pharmacol 186:114483. https:\/\/doi.org\/10.1016\/j.bcp.2021.114483","journal-title":"Biochem Pharmacol"},{"key":"10807_CR87","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.21873\/anticanres.13647","volume":"39","author":"T Ohara","year":"2019","unstructured":"Ohara T, Mori T (2019) Antiproliferative effects of short-chain fatty acids on human colorectal cancer cells via gene expression inhibition. Anticancer Res 39:4659\u20134666. https:\/\/doi.org\/10.21873\/anticanres.13647","journal-title":"Anticancer Res"},{"key":"10807_CR88","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.2174\/0929867325666180530102050","volume":"27","author":"SD Gomes","year":"2018","unstructured":"Gomes SD, Oliveira CS, Azevedo-Silva J et al (2018) The role of diet related short-chain fatty acids in colorectal cancer metabolism and survival: prevention and therapeutic implications. Curr Med Chem 27:4087\u20134108. https:\/\/doi.org\/10.2174\/0929867325666180530102050","journal-title":"Curr Med Chem"},{"key":"10807_CR89","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clnesp.2021.09.740","volume":"46","author":"F Genua","year":"2021","unstructured":"Genua F, Mirkovi\u0107 B, Mullee A (2021) Association of circulating short chain fatty acid levels with colorectal adenomas and colorectal cancer. Clin Nutr ESPEN 46:297\u2013304. https:\/\/doi.org\/10.1016\/j.clnesp.2021.09.740","journal-title":"Clin Nutr ESPEN"},{"key":"10807_CR90","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G et al (2014) The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10807_CR91","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/japtr.japtr_116_21","volume":"12","author":"YB Soemarie","year":"2021","unstructured":"Soemarie YB, Milanda T, Barliana MI (2021) Fermented foods as probiotics: a review. J Adv Pharm Technol Res 12:335\u2013339. https:\/\/doi.org\/10.4103\/japtr.japtr_116_21","journal-title":"J Adv Pharm Technol Res"},{"key":"10807_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103931","volume":"140","author":"H Yang","year":"2020","unstructured":"Yang H, Sun Y, Cai R et al (2020) The impact of dietary fiber and probiotics in infectious diseases. Microb Pathog 140:103931. https:\/\/doi.org\/10.1016\/j.micpath.2019.103931","journal-title":"Microb Pathog"},{"key":"10807_CR93","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/jgh.13471","volume":"32","author":"X Zhuang","year":"2017","unstructured":"Zhuang X, Xiong L, Li L et al (2017) Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol Hepatol 32:28\u201338. https:\/\/doi.org\/10.1111\/jgh.13471","journal-title":"J Gastroenterol Hepatol"},{"key":"10807_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li M, Chen Q et al (2022) Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun 13:3432. https:\/\/doi.org\/10.1038\/s41467-022-31171-0","journal-title":"Nat Commun"},{"key":"10807_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08915-5","volume":"12","author":"AbdullahG Alkushi","year":"2022","unstructured":"Alkushi AbdullahG, Abdelfattah-Hassan A, Eldoumani H et al (2022) Probiotics-loaded nanoparticles attenuated colon inflammation, oxidative stress, and apoptosis in colitis. Sci Rep 12:5116. https:\/\/doi.org\/10.1038\/s41598-022-08915-5","journal-title":"Sci Rep"},{"key":"10807_CR96","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00284-019-01679-8","volume":"76","author":"A G\u00f3rska","year":"2019","unstructured":"G\u00f3rska A, Przystupski D, Niemczura MJ, Kulbacka J (2019) Probiotic bacteria: a promising tool in cancer prevention and therapy. Curr Microbiol 76:939\u2013949. https:\/\/doi.org\/10.1007\/s00284-019-01679-8","journal-title":"Curr Microbiol"},{"key":"10807_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112359","volume":"14","author":"S Gomes","year":"2022","unstructured":"Gomes S, Baltazar F, Silva E, Preto A (2022) Microbiota-derived short-chain fatty acids: new road in colorectal cancer therapy. Pharmaceutics 14:2359. https:\/\/doi.org\/10.3390\/pharmaceutics14112359","journal-title":"Pharmaceutics"},{"key":"10807_CR98","first-page":"1411","volume":"57","author":"T Ohara","year":"2010","unstructured":"Ohara T, Yoshino K, Kitajima M (2010) Possibility of preventing colorectal carcinogenesis with probiotics. Hepato-Gastroenterol 57:1411\u20131415","journal-title":"Hepato-Gastroenterol"},{"key":"10807_CR99","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1093\/jn\/135.12.2878","volume":"135","author":"S Ohkawara","year":"2005","unstructured":"Ohkawara S, Furuya H, Nagashima K et al (2005) Oral administration of Butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice 1, 2. J Nutr 135:2878\u20132883. https:\/\/doi.org\/10.1093\/jn\/135.12.2878","journal-title":"J Nutr"},{"key":"10807_CR100","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/01635580701397608","volume":"59","author":"S Ohkawara","year":"2007","unstructured":"Ohkawara S, Furuya H, Nagashima K (2007) Effect of oral administration of Butyrivibrio fibrisolvens MDT-1, a gastrointestinal bacterium, on 3-methylcholanthrene-induced tumor in mice. Nutr Cancer 59:92\u201398. https:\/\/doi.org\/10.1080\/01635580701397608","journal-title":"Nutr Cancer"},{"key":"10807_CR101","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1128\/cvi.00267-06","volume":"13","author":"S Ohkawara","year":"2006","unstructured":"Ohkawara S, Furuya H, Nagashima K et al (2006) Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in mice. Clin Vaccine Immunol 13:1231\u20131236. https:\/\/doi.org\/10.1128\/cvi.00267-06","journal-title":"Clin Vaccine Immunol"},{"key":"10807_CR102","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jam.12499","volume":"117","author":"J Zhu","year":"2014","unstructured":"Zhu J, Zhu C, Ge S et al (2014) Lactobacillus salivarius Ren prevent the early colorectal carcinogenesis in 1, 2-dimethylhydrazine-induced rat model. J Appl Microbiol 117:208\u2013216. https:\/\/doi.org\/10.1111\/jam.12499","journal-title":"J Appl Microbiol"},{"key":"10807_CR103","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2217\/fmb.15.66","volume":"10","author":"Z-F Chen","year":"2015","unstructured":"Chen Z-F, Ai L-Y, Wang J-L et al (2015) Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiol 10:1433\u20131445. https:\/\/doi.org\/10.2217\/fmb.15.66","journal-title":"Future Microbiol"},{"key":"10807_CR104","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3920\/bm2017.0035","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Gu Y, Fang K et al (2018) Lactobacillus acidophilus and Clostridium butyricum ameliorate colitis in murine by strengthening the gut barrier function and decreasing inflammatory factors. Benef Microbes 9:775\u2013788. https:\/\/doi.org\/10.3920\/bm2017.0035","journal-title":"Benef Microbes"},{"key":"10807_CR105","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.canlet.2019.11.019","volume":"469","author":"D Chen","year":"2020","unstructured":"Chen D, Jin D, Huang S et al (2020) Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett 469:456\u2013467. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.019","journal-title":"Cancer Lett"},{"key":"10807_CR106","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12010-012-9995-y","volume":"169","author":"M Thirabunyanon","year":"2013","unstructured":"Thirabunyanon M, Hongwittayakorn P (2013) Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol 169:511\u2013525. https:\/\/doi.org\/10.1007\/s12010-012-9995-y","journal-title":"Appl Biochem Biotechnol"},{"key":"10807_CR107","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01635581.2010.516873","volume":"63","author":"A Grishina","year":"2011","unstructured":"Grishina A, Kulikova I, Alieva L et al (2011) Antigenotoxic effect of kefir and ayran supernatants on fecal water-induced DNA damage in human colon cells. Nutr Cancer 63:73\u201379. https:\/\/doi.org\/10.1080\/01635581.2010.516873","journal-title":"Nutr Cancer"},{"key":"10807_CR108","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5897\/ajfs2015.1276","volume":"9","author":"T Gemechu","year":"2015","unstructured":"Gemechu T (2015) Review on lactic acid bacteria function in milk fermentation and preservation. Afr J Food Sci 9:170\u2013175. https:\/\/doi.org\/10.5897\/ajfs2015.1276","journal-title":"Afr J Food Sci"},{"key":"10807_CR109","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013792","volume":"97","author":"K Jia","year":"2018","unstructured":"Jia K, Tong X, Wang R, Song X (2018) The clinical effects of probiotics for inflammatory bowel disease. Medicine (Baltimore) 97:e13792. https:\/\/doi.org\/10.1097\/md.0000000000013792","journal-title":"Medicine (Baltimore)"},{"key":"10807_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30114-4","volume":"8","author":"R Nagpal","year":"2018","unstructured":"Nagpal R, Wang S, Ahmadi S et al (2018) Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. Sci Rep 8:12649. https:\/\/doi.org\/10.1038\/s41598-018-30114-4","journal-title":"Sci Rep"},{"key":"10807_CR111","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","volume":"118","author":"J-W Wang","year":"2019","unstructured":"Wang J-W, Kuo C-H, Kuo F-C (2019) Fecal microbiota transplantation: review and update. J Formos Med Assoc 118:S23\u2013S31. https:\/\/doi.org\/10.1016\/j.jfma.2018.08.011","journal-title":"J Formos Med Assoc"},{"key":"10807_CR112","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00004836-200307000-00012","volume":"37","author":"TJ Borody","year":"2003","unstructured":"Borody TJ, Warren EF, Leis S et al (2003) Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 37:42\u201347. https:\/\/doi.org\/10.1097\/00004836-200307000-00012","journal-title":"J Clin Gastroenterol"},{"key":"10807_CR113","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/cid\/civ994","volume":"62","author":"SP Costello","year":"2016","unstructured":"Costello SP, Tucker EC, Brooy JL (2016) Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection. Clin Infect Dis 62:908\u2013914. https:\/\/doi.org\/10.1093\/cid\/civ994","journal-title":"Clin Infect Dis"},{"key":"10807_CR114","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s0140-6736(89)91183-5","volume":"333","author":"B JustinD","year":"1989","unstructured":"JustinD B, Brinkman M (1989) Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 333:164. https:\/\/doi.org\/10.1016\/s0140-6736(89)91183-5","journal-title":"Lancet"},{"key":"10807_CR115","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5946\/ce.2015.117","volume":"49","author":"HH Choi","year":"2016","unstructured":"Choi HH, Cho Y-S (2016) Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc 49:257\u2013265. https:\/\/doi.org\/10.5946\/ce.2015.117","journal-title":"Clin Endosc"},{"key":"10807_CR116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1756283x12461395","volume":"6","author":"C Probert","year":"2013","unstructured":"Probert C (2013) Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma. Ther Adv Gastroenterol 6:33\u201338. https:\/\/doi.org\/10.1177\/1756283x12461395","journal-title":"Ther Adv Gastroenterol"},{"key":"10807_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187737","volume":"12","author":"T Fukuda","year":"2017","unstructured":"Fukuda T, Naganuma M, Sugimoto S et al (2017) The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: a report from the IBD registry. PLoS ONE 12:e0187737. https:\/\/doi.org\/10.1371\/journal.pone.0187737","journal-title":"PLoS ONE"},{"key":"10807_CR118","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2036.2012.05220.x","volume":"36","author":"JL Anderson","year":"2012","unstructured":"Anderson JL, Edney RJ, Whelan K (2012) Systematic review: Faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 36:503\u2013516. https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05220.x","journal-title":"Aliment Pharmacol Ther"},{"key":"10807_CR119","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.crohns.2014.08.006","volume":"8","author":"RJ Colman","year":"2014","unstructured":"Colman RJ, Rubin DT (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 8:1569\u20131581. https:\/\/doi.org\/10.1016\/j.crohns.2014.08.006","journal-title":"J Crohns Colitis"},{"key":"10807_CR120","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi P, Surette MG, Kim PT et al (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149:102-109.e6. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.001","journal-title":"Gastroenterology"},{"key":"10807_CR121","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/ajg.2013.257","volume":"108","author":"S Angelberger","year":"2013","unstructured":"Angelberger S, Reinisch W, Makristathis A et al (2013) Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 108:1620\u20131630. https:\/\/doi.org\/10.1038\/ajg.2013.257","journal-title":"Am J Gastroenterol"},{"key":"10807_CR122","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1097\/mib.0000000000001228","volume":"23","author":"N Narula","year":"2017","unstructured":"Narula N, Kassam Z, Yuan Y (2017) Systematic review and meta-analysis. Inflamm Bowel Dis 23:1702\u20131709. https:\/\/doi.org\/10.1097\/mib.0000000000001228","journal-title":"Inflamm Bowel Dis"},{"key":"10807_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd012774.pub2","volume":"2018","author":"A Imdad","year":"2018","unstructured":"Imdad A, Nicholson MR, Tanner-Smith EE (2018) Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2018:CD012774. https:\/\/doi.org\/10.1002\/14651858.cd012774.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"10807_CR124","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","volume":"156","author":"S Paramsothy","year":"2019","unstructured":"Paramsothy S, Nielsen S, Kamm MA et al (2019) Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology 156:1440-1454.e2. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.001","journal-title":"Gastroenterology"},{"key":"10807_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-021-01513-6","volume":"20","author":"H Fang","year":"2021","unstructured":"Fang H, Fu L, Li X et al (2021) Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study. Microb Cell Fact 20:18. https:\/\/doi.org\/10.1186\/s12934-021-01513-6","journal-title":"Microb Cell Fact"},{"key":"10807_CR126","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/ecco-jcc\/jjx180.018","volume":"12","author":"S Paramsothy","year":"2018","unstructured":"Paramsothy S, Kamm M, Nielsen S et al (2018) OP019 In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study). J Crohn\u2019s Colitis 12:S13\u2013S14. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx180.018","journal-title":"J Crohn\u2019s Colitis"},{"key":"10807_CR127","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/mcg.0000000000000155","volume":"48","author":"TJ Borody","year":"2014","unstructured":"Borody TJ, Finlayson S, Paramsothy S (2014) Is Crohn\u2019s disease ready for fecal microbiota transplantation&quest. J Clin Gastroenterol 48:582\u2013583. https:\/\/doi.org\/10.1097\/mcg.0000000000000155","journal-title":"J Clin Gastroenterol"},{"key":"10807_CR128","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3748\/wjg.v19.i41.7213","volume":"19","author":"F-M Zhang","year":"2013","unstructured":"Zhang F-M, Wang H-G, Wang M et al (2013) Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn\u2019s disease. World J Gastroenterol 19:7213\u20137216. https:\/\/doi.org\/10.3748\/wjg.v19.i41.7213","journal-title":"World J Gastroenterol"},{"key":"10807_CR129","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/ijmm.2017.3022","volume":"40","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Zhang L, Lu Q et al (2017) Identification of different macrophage subpopulations with distinct activities in a mouse model of oxygen-induced retinopathy. Int J Mol Med 40:281\u2013292. https:\/\/doi.org\/10.3892\/ijmm.2017.3022","journal-title":"Int J Mol Med"},{"key":"10807_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008668","volume":"5","author":"M Daigneault","year":"2010","unstructured":"Daigneault M, Preston JA, Marriott HM (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5:e8668. https:\/\/doi.org\/10.1371\/journal.pone.0008668","journal-title":"PLoS ONE"},{"key":"10807_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1084636","volume":"14","author":"Q Wei","year":"2023","unstructured":"Wei Q, Deng Y, Yang Q et al (2023) The markers to delineate different phenotypes of macrophages related to metabolic disorders. Front Immunol 14:1084636. https:\/\/doi.org\/10.3389\/fimmu.2023.1084636","journal-title":"Front Immunol"},{"key":"10807_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.886061","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Xu Y, Wang X et al (2022) Probiotic cocktail alleviates intestinal inflammation through improving gut microbiota and metabolites in colitis mice. Front Cell Infect Microbiol 12:886061. https:\/\/doi.org\/10.3389\/fcimb.2022.886061","journal-title":"Front Cell Infect Microbiol"},{"key":"10807_CR133","doi-asserted-by":"publisher","first-page":"13337","DOI":"10.1021\/jf203444d","volume":"59","author":"N-P Foo","year":"2011","unstructured":"Foo N-P, Yang HO, Chiu H-H et al (2011) Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem 59:13337\u201313345. https:\/\/doi.org\/10.1021\/jf203444d","journal-title":"J Agric Food Chem"},{"key":"10807_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00723","volume":"8","author":"YS Nanjundaiah","year":"2020","unstructured":"Nanjundaiah YS, Wright DA, Baydoun AR et al (2020) Modulation of macrophage function by lactobacillus-conditioned medium. Front Cell Dev Biol 8:723. https:\/\/doi.org\/10.3389\/fcell.2020.00723","journal-title":"Front Cell Dev Biol"},{"key":"10807_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56622-0","volume":"14","author":"MAA Al-Najjar","year":"2024","unstructured":"Al-Najjar MAA, Abdulrazzaq SB, Alzaghari LF et al (2024) Evaluation of immunomodulatory potential of probiotic conditioned medium on murine macrophages. Sci Rep 14:7126. https:\/\/doi.org\/10.1038\/s41598-024-56622-0","journal-title":"Sci Rep"},{"key":"10807_CR136","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.antiviral.2007.03.013","volume":"75","author":"M Ivec","year":"2007","unstructured":"Ivec M, Boti\u0107 T, Koren S et al (2007) Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. Antiviral Res 75:266\u2013274. https:\/\/doi.org\/10.1016\/j.antiviral.2007.03.013","journal-title":"Antiviral Res"},{"key":"10807_CR137","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13721","author":"KD Winther","year":"2023","unstructured":"Winther KD, Boll EJ, Sandvang D, Williams AR (2023) Probiotic Bacillus spp. enhance TLR3-mediated TNF signalling in macrophages. Immunology. https:\/\/doi.org\/10.1111\/imm.13721","journal-title":"Immunology"},{"key":"10807_CR138","doi-asserted-by":"publisher","first-page":"1000227","DOI":"10.4172\/2155-9899.1000227","volume":"5","author":"AI Raymond","year":"2014","unstructured":"Raymond AI, Fern JB et al (2014) The probiotic mixture VSL#3 alters the morphology and secretion profile of both polarized and unpolarized human macrophages in a polarization-dependent manner. J Clin Cell Immunol 5:1000227. https:\/\/doi.org\/10.4172\/2155-9899.1000227","journal-title":"J Clin Cell Immunol"},{"key":"10807_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02280","volume":"8","author":"VH Matsubara","year":"2017","unstructured":"Matsubara VH, Ishikawa KH, Ando-Suguimoto ES et al (2017) Probiotic bacteria alter pattern-recognition receptor expression and cytokine profile in a human macrophage model challenged with Candida albicans and lipopolysaccharide. Front Microbiol 8:2280. https:\/\/doi.org\/10.3389\/fmicb.2017.02280","journal-title":"Front Microbiol"},{"key":"10807_CR140","doi-asserted-by":"publisher","DOI":"10.11648\/j.acis.s.2015030201.11","volume":"3","author":"NY Habil","year":"2015","unstructured":"Habil NY (2015) Probiotic induce macrophage cytokine production via activation of STAT-3 pathway. Automation, Control and Intelligent Systems 3:1. https:\/\/doi.org\/10.11648\/j.acis.s.2015030201.11","journal-title":"Automation, Control and Intelligent Systems"},{"key":"10807_CR141","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.3168\/jds.2017-13868","volume":"101","author":"R Kaji","year":"2018","unstructured":"Kaji R, Kiyoshima-Shibata J, Tsujibe S et al (2018) Short communication: Probiotic induction of interleukin-10 and interleukin-12 production by macrophages is modulated by co-stimulation with microbial components. J Dairy Sci 101:2838\u20132841. https:\/\/doi.org\/10.3168\/jds.2017-13868","journal-title":"J Dairy Sci"},{"key":"10807_CR142","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.chom.2013.05.013","volume":"13","author":"A Hayashi","year":"2013","unstructured":"Hayashi A, Sato T, Kamada N et al (2013) A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe 13:711\u2013722. https:\/\/doi.org\/10.1016\/j.chom.2013.05.013","journal-title":"Cell Host Microbe"},{"key":"10807_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07359-8","volume":"9","author":"C Burrello","year":"2018","unstructured":"Burrello C, Garavaglia F, Cribi\u00f9 FM et al (2018) Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells. Nat Commun 9:5184. https:\/\/doi.org\/10.1038\/s41467-018-07359-8","journal-title":"Nat Commun"},{"key":"10807_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04193-4","volume":"23","author":"B Diwan","year":"2023","unstructured":"Diwan B, Yadav R, Singh A et al (2023) Murine sterile fecal filtrate is a potent pharmacological agent that exerts age-independent immunomodulatory effects in RAW264.7 macrophages. BMC Complement Med Ther 23:362. https:\/\/doi.org\/10.1186\/s12906-023-04193-4","journal-title":"BMC Complement Med Ther"},{"key":"10807_CR145","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ni.2768","volume":"15","author":"PB Watchmaker","year":"2014","unstructured":"Watchmaker PB, Lahl K, Lee M (2014) Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. Nat Immunol 15:98\u2013108. https:\/\/doi.org\/10.1038\/ni.2768","journal-title":"Nat Immunol"},{"key":"10807_CR146","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1136\/gut.2003.037325","volume":"53","author":"AL Hart","year":"2004","unstructured":"Hart AL, Lammers K, Brigidi P et al (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53:1602. https:\/\/doi.org\/10.1136\/gut.2003.037325","journal-title":"Gut"},{"key":"10807_CR147","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1128\/iai.72.6.3299-3309.2004","volume":"72","author":"M Drakes","year":"2004","unstructured":"Drakes M, Blanchard T, Czinn S (2004) Bacterial probiotic modulation of dendritic cells. Infect Immun 72:3299\u20133309. https:\/\/doi.org\/10.1128\/iai.72.6.3299-3309.2004","journal-title":"Infect Immun"},{"key":"10807_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000313","volume":"2","author":"B Foligne","year":"2007","unstructured":"Foligne B, Zoumpopoulou G, Dewulf J (2007) A key role of dendritic cells in probiotic functionality. PLoS ONE 2:e313. https:\/\/doi.org\/10.1371\/journal.pone.0000313","journal-title":"PLoS ONE"},{"key":"10807_CR149","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3748\/wjg.v18.i12.1308","volume":"18","author":"JY Kim","year":"2012","unstructured":"Kim JY, Park MS, Ji GE (2012) Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells. World J Gastroenterol 18:1308\u20131318. https:\/\/doi.org\/10.3748\/wjg.v18.i12.1308","journal-title":"World J Gastroenterol"},{"key":"10807_CR150","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.imbio.2013.08.012","volume":"219","author":"J You","year":"2014","unstructured":"You J, Dong H, Mann ER et al (2014) Probiotic modulation of dendritic cell function is influenced by ageing. Immunobiology 219:138\u2013148. https:\/\/doi.org\/10.1016\/j.imbio.2013.08.012","journal-title":"Immunobiology"},{"key":"10807_CR151","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.3748\/wjg.v25.i36.5469","volume":"25","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Yang W-R, Wang X-H (2019) Clostridium butyricum alleviates intestinal low-grade inflammation in TNBS-induced irritable bowel syndrome in mice by regulating functional status of lamina propria dendritic cells. World J Gastroenterol 25:5469\u20135482. https:\/\/doi.org\/10.3748\/wjg.v25.i36.5469","journal-title":"World J Gastroenterol"},{"key":"10807_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111212","volume":"126","author":"D Xi","year":"2024","unstructured":"Xi D, Liu P, Feng Y et al (2024) Fecal microbiota transplantation regulates the microbiota-gut-spinal cord axis to promote recovery after spinal cord injury. Int Immunopharmacol 126:111212. https:\/\/doi.org\/10.1016\/j.intimp.2023.111212","journal-title":"Int Immunopharmacol"},{"key":"10807_CR153","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2337\/db20-1177","volume":"70","author":"E L\u00e9cuyer","year":"2021","unstructured":"L\u00e9cuyer E, Roy TL, Gestin A et al (2021) Tolerogenic dendritic cells shape a transmissible gut microbiota that protects from metabolic diseases. Diabetes 70:2067\u20132080. https:\/\/doi.org\/10.2337\/db20-1177","journal-title":"Diabetes"},{"key":"10807_CR154","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350:1079\u20131084. https:\/\/doi.org\/10.1126\/science.aad1329","journal-title":"Science"},{"key":"10807_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5120118","volume":"5","author":"O W\u00e9ra","year":"2016","unstructured":"W\u00e9ra O, Lancellotti P, Oury C (2016) The dual role of neutrophils in inflammatory bowel diseases. J Clin Med 5:118. https:\/\/doi.org\/10.3390\/jcm5120118","journal-title":"J Clin Med"},{"key":"10807_CR156","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.4049\/jimmunol.1302286","volume":"192","author":"L Vong","year":"2014","unstructured":"Vong L, Lorentz RJ, Assa A et al (2014) Probiotic Lactobacillus rhamnosus inhibits the formation of neutrophil extracellular traps. J Immunol 192:1870\u20131877. https:\/\/doi.org\/10.4049\/jimmunol.1302286","journal-title":"J Immunol"},{"key":"10807_CR157","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","volume":"48","author":"V Stadlbauer","year":"2008","unstructured":"Stadlbauer V, Mookerjee RP, Hodges S et al (2008) Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol 48:945\u2013951. https:\/\/doi.org\/10.1016\/j.jhep.2008.02.015","journal-title":"J Hepatol"},{"key":"10807_CR158","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","volume":"54","author":"JM Michot","year":"2016","unstructured":"Michot JM, Bigenwald C, Champiat S et al (2016) Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54:139\u2013148. https:\/\/doi.org\/10.1016\/j.ejca.2015.11.016","journal-title":"Eur J Cancer"},{"key":"10807_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-015-0003-0","volume":"15","author":"O Wattanarat","year":"2015","unstructured":"Wattanarat O, Makeudom A, Sastraruji T (2015) Enhancement of salivary human neutrophil peptide 1\u20133 levels by probiotic supplementation. BMC Oral Health 15:19. https:\/\/doi.org\/10.1186\/s12903-015-0003-0","journal-title":"BMC Oral Health"},{"key":"10807_CR160","doi-asserted-by":"publisher","first-page":"637","DOI":"10.17221\/72\/2017-vetmed","volume":"62","author":"T Sustrova","year":"2017","unstructured":"Sustrova T, Ondrackova P, Leva L et al (2017) Effect of probiotics on the viability of porcine and human neutrophils in vitro. Vet Med (Praha) 62:637\u2013646. https:\/\/doi.org\/10.17221\/72\/2017-vetmed","journal-title":"Vet Med (Praha)"},{"key":"10807_CR161","doi-asserted-by":"publisher","first-page":"94","DOI":"10.12938\/bmfh.2022-038","volume":"42","author":"S Saito","year":"2023","unstructured":"Saito S, Kelel M (2023) Oral administration of Lacticaseibacillus casei ATCC393 promotes angiogenesis by enhancing neutrophil activity in a murine hind-limb ischemia model. Biosci Microbiota Food Health 42:94\u201399. https:\/\/doi.org\/10.12938\/bmfh.2022-038","journal-title":"Biosci Microbiota Food Health"},{"key":"10807_CR162","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","volume":"11","author":"T Zhang","year":"2020","unstructured":"Zhang T, Lu G, Zhao Z et al (2020) Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell 11:251\u2013266. https:\/\/doi.org\/10.1007\/s13238-019-00684-8","journal-title":"Protein Cell"},{"key":"10807_CR163","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.2174\/138161211798357881","volume":"17","author":"P Heneberg","year":"2011","unstructured":"Heneberg P (2011) Mast cells and basophils: trojan horses of conventional lin- stem\/progenitor cell isolates. Curr Pharm Des 17:3753\u20133771. https:\/\/doi.org\/10.2174\/138161211798357881","journal-title":"Curr Pharm Des"},{"key":"10807_CR164","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3748\/wjg.v10.i3.309","volume":"10","author":"S-H He","year":"2004","unstructured":"He S-H (2004) Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10:309\u2013318. https:\/\/doi.org\/10.3748\/wjg.v10.i3.309","journal-title":"World J Gastroenterol"},{"key":"10807_CR165","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/mib.0000000000000142","volume":"20","author":"MJ Hamilton","year":"2014","unstructured":"Hamilton MJ, Frei SM, Stevens RL (2014) The multifaceted mast cell in inflammatory bowel disease. Inflamm Bowel Dis 20:2364\u20132378. https:\/\/doi.org\/10.1097\/mib.0000000000000142","journal-title":"Inflamm Bowel Dis"},{"key":"10807_CR166","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1073\/pnas.1005758108","volume":"108","author":"MJ Hamilton","year":"2011","unstructured":"Hamilton MJ, Sinnamon MJ, Lyng GD et al (2011) Essential role for mast cell tryptase in acute experimental colitis. Proc Natl Acad Sci U S A 108:290\u2013295. https:\/\/doi.org\/10.1073\/pnas.1005758108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10807_CR167","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3748\/wjg.v17.i6.750","volume":"17","author":"A Oksaharju","year":"2011","unstructured":"Oksaharju A, Kankainen M, Kekkonen RA et al (2011) Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. World J Gastroenterol 17:750\u2013759. https:\/\/doi.org\/10.3748\/wjg.v17.i6.750","journal-title":"World J Gastroenterol"},{"key":"10807_CR168","doi-asserted-by":"publisher","first-page":"822","DOI":"10.5152\/tjg.2022.21550","volume":"33","author":"A Hizay","year":"2022","unstructured":"Hizay A, Celik NK et al (2022) Probiotics in experimental ulcerative colitis: mast cell density and neuronal hypertrophy. Turk J Gastroenterol 33:822\u2013830. https:\/\/doi.org\/10.5152\/tjg.2022.21550","journal-title":"Turk J Gastroenterol"},{"key":"10807_CR169","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5056\/jnm20004","volume":"26","author":"Y-J Li","year":"2020","unstructured":"Li Y-J, Li J, Dai C (2020) The role of intestinal microbiota and mast cell in a rat model of visceral hypersensitivity. J Neurogastroenterol Motil 26:529\u2013538. https:\/\/doi.org\/10.5056\/jnm20004","journal-title":"J Neurogastroenterol Motil"},{"issue":"4","key":"10807_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044157","volume":"24","author":"R di Vito","year":"2023","unstructured":"di Vito R, Mezza AD, Conte C, Traina G (2023) The crosstalk between intestinal epithelial cells and mast cells is modulated by the probiotic supplementation in co-culture models. Int J Mol Sci 24(4):4157. https:\/\/doi.org\/10.3390\/ijms24044157","journal-title":"Int J Mol Sci"},{"key":"10807_CR171","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","volume":"38","author":"SP Hogan","year":"2008","unstructured":"Hogan SP, Rosenberg HF, Moqbel R et al (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38:709\u2013750. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.02958.x","journal-title":"Clin Exp Allergy"},{"key":"10807_CR172","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/ibd\/izz024","volume":"25","author":"RT Filippone","year":"2019","unstructured":"Filippone RT, Sahakian L, Apostolopoulos V, Nurgali K (2019) Eosinophils in inflammatory bowel disease. Inflamm Bowel Dis 25:1140\u20131151. https:\/\/doi.org\/10.1093\/ibd\/izz024","journal-title":"Inflamm Bowel Dis"},{"key":"10807_CR173","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jaci.2014.05.025","volume":"134","author":"L Chapuy","year":"2014","unstructured":"Chapuy L, Bsat M, Mehta H et al (2014) Basophils increase in Crohn disease and ulcerative colitis and favor mesenteric lymph node memory TH17\/TH1 response. J Allergy Clin Immunol 134:978-981.e1. https:\/\/doi.org\/10.1016\/j.jaci.2014.05.025","journal-title":"J Allergy Clin Immunol"},{"key":"10807_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010067","volume":"17","author":"DS Nogueira","year":"2021","unstructured":"Nogueira DS, de Oliveira LM, Amorim CCO et al (2021) Eosinophils mediate SIgA production triggered by TLR2 and TLR4 to control Ascaris suum infection in mice. PLoS Pathog 17:e1010067. https:\/\/doi.org\/10.1371\/journal.ppat.1010067","journal-title":"PLoS Pathog"},{"issue":"2","key":"10807_CR175","doi-asserted-by":"publisher","first-page":"AB65","DOI":"10.1016\/j.jaci.2019.12.728","volume":"145","author":"YH Kim","year":"2020","unstructured":"Kim YH, Park H, Jung A-Y (2020) Probiotics attenuates allergic airway inflammation via downregulation of hypoxia signaling. J Allergy Clin Immunol 145:AB65. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.728","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10807_CR176","doi-asserted-by":"publisher","first-page":"AB185","DOI":"10.1016\/j.jaci.2009.12.725","volume":"125","author":"K Hosoki","year":"2010","unstructured":"Hosoki K, Nagao M, Noma Y et al (2010) Differential activation of eosinophils by \u201cprobiotic\u201d Bifidobacterium bifidum and \u201cpathogenic\u201d Clostridium difficile. J Allergy Clin Immunol 125:AB185. https:\/\/doi.org\/10.1016\/j.jaci.2009.12.725","journal-title":"J Allergy Clin Immunol"},{"key":"10807_CR177","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/iid3.113","volume":"4","author":"L Cassard","year":"2016","unstructured":"Cassard L, Lalanne AI, Garault P et al (2016) Individual strains of Lactobacillus paracasei differentially inhibit human basophil and mouse mast cell activation. Immunity Inflamm Dis 4:289\u2013299. https:\/\/doi.org\/10.1002\/iid3.113","journal-title":"Immunity Inflamm Dis"},{"key":"10807_CR178","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jaci.2017.11.053","volume":"142","author":"L Cassard","year":"2018","unstructured":"Cassard L, Sperber K, Buivan T-P et al (2018) Basophils from allergic patients are neither hyperresponsive to activation signals nor hyporesponsive to inhibition signals. J Allergy Clin Immunol 142:1548\u20131557. https:\/\/doi.org\/10.1016\/j.jaci.2017.11.053","journal-title":"J Allergy Clin Immunol"},{"key":"10807_CR179","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s10620-018-5416-6","volume":"64","author":"Y-J Li","year":"2019","unstructured":"Li Y-J, Dai C, Jiang M (2019) Mechanisms of probiotic VSL#3 in a rat model of visceral hypersensitivity involves the mast cell-PAR2-TRPV1 pathway. Dig Dis Sci 64:1182\u20131192. https:\/\/doi.org\/10.1007\/s10620-018-5416-6","journal-title":"Dig Dis Sci"},{"key":"10807_CR180","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s12276-021-00627-6","volume":"53","author":"J-H Kim","year":"2021","unstructured":"Kim J-H, Kim K, Kim W (2021) Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy. Exp Mol Med 53:907\u2013916. https:\/\/doi.org\/10.1038\/s12276-021-00627-6","journal-title":"Exp Mol Med"},{"key":"10807_CR181","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2021.10.002","volume":"162","author":"M Brusilovsky","year":"2022","unstructured":"Brusilovsky M, Bao R, Rochman M et al (2022) Host\u2013microbiota interactions in the esophagus during homeostasis and allergic inflammation. Gastroenterology 162:521-534.e8. https:\/\/doi.org\/10.1053\/j.gastro.2021.10.002","journal-title":"Gastroenterology"},{"key":"10807_CR182","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M et al (2008) Functions of natural killer cells. Nat Immunol 9:503\u2013510. https:\/\/doi.org\/10.1038\/ni1582","journal-title":"Nat Immunol"},{"key":"10807_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1192907","volume":"14","author":"E Shin","year":"2023","unstructured":"Shin E, Bak SH, Park T (2023) Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. Front Immunol 14:1192907. https:\/\/doi.org\/10.3389\/fimmu.2023.1192907","journal-title":"Front Immunol"},{"key":"10807_CR184","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/413982","volume":"2014","author":"D Ivanova","year":"2014","unstructured":"Ivanova D, Krempels R, Ryfe J et al (2014) NK cells in mucosal defense against infection. BioMed Res Int 2014:413982. https:\/\/doi.org\/10.1155\/2014\/413982","journal-title":"BioMed Res Int"},{"key":"10807_CR185","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1023\/a:1010979225018","volume":"21","author":"HS Gill","year":"2001","unstructured":"Gill HS, Rutherfurd KJ, Cross ML (2001) Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 21:264\u2013271. https:\/\/doi.org\/10.1023\/a:1010979225018","journal-title":"J Clin Immunol"},{"key":"10807_CR186","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/07315724.2001.10719027","volume":"20","author":"Y-H Sheih","year":"2001","unstructured":"Sheih Y-H, Chiang B-L, Wang L-H et al (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20:149\u2013156. https:\/\/doi.org\/10.1080\/07315724.2001.10719027","journal-title":"J Am Coll Nutr"},{"key":"10807_CR187","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijfoodmicro.2005.08.019","volume":"107","author":"M Olivares","year":"2006","unstructured":"Olivares M, D\u00edaz-Ropero MP, G\u00f3mez N et al (2006) Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol 107:104\u2013111. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2005.08.019","journal-title":"Int J Food Microbiol"},{"key":"10807_CR188","first-page":"47","volume":"9","author":"M Olivares","year":"2006","unstructured":"Olivares M, D\u00edaz-Ropero MP, G\u00f3mez N et al (2006) The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol\u202f: Off J Span Soc Microbiol 9:47\u201352","journal-title":"Int Microbiol : Off J Span Soc Microbiol"},{"key":"10807_CR189","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/s0022029906002068","volume":"73","author":"M Olivares","year":"2006","unstructured":"Olivares M, D\u00edaz-Ropero MP, G\u00f3mez N et al (2006) Dietary deprivation of fermented foods causes a fall in innate immune response. Lactic acid bacteria can counteract the immunological effect of this deprivation. J Dairy Res 73:492\u2013498. https:\/\/doi.org\/10.1017\/s0022029906002068","journal-title":"J Dairy Res"},{"key":"10807_CR190","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/jmf.2006.9.321","volume":"9","author":"H-S Kim","year":"2006","unstructured":"Kim H-S, Park H, Cho I-Y et al (2006) Dietary supplementation of probiotic Bacillus polyfermenticus, bispan strain, modulates natural killer cell and T cell subset populations and immunoglobulin G levels in human subjects. J Med Food 9:321\u2013327. https:\/\/doi.org\/10.1089\/jmf.2006.9.321","journal-title":"J Med Food"},{"key":"10807_CR191","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1017\/s0007114511005824","volume":"108","author":"H Dong","year":"2012","unstructured":"Dong H, Rowland I, Yaqoob P (2012) Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 108:459\u2013470. https:\/\/doi.org\/10.1017\/s0007114511005824","journal-title":"Br J Nutr"},{"key":"10807_CR192","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41430-020-0670-z","volume":"74","author":"Q Gui","year":"2020","unstructured":"Gui Q, Wang A, Zhao X et al (2020) Effects of probiotic supplementation on natural killer cell function in healthy elderly individuals: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 74:1630\u20131637. https:\/\/doi.org\/10.1038\/s41430-020-0670-z","journal-title":"Eur J Clin Nutr"},{"key":"10807_CR193","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1574-695x.2010.00658.x","volume":"59","author":"F Ibrahim","year":"2010","unstructured":"Ibrahim F, Ruvio S, Granlund L et al (2010) Probiotics and immunosenescence: cheese as a carrier. FEMS Immunol Med Microbiol 59:53\u201359. https:\/\/doi.org\/10.1111\/j.1574-695x.2010.00658.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10807_CR194","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2249.2010.04173.x","volume":"161","author":"H Dong","year":"2010","unstructured":"Dong H, Rowland I, Tuohy KM et al (2010) Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clin Exp Immunol 161:378\u2013388. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04173.x","journal-title":"Clin Exp Immunol"},{"key":"10807_CR195","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/intimm\/dxm103","volume":"19","author":"LN Fink","year":"2007","unstructured":"Fink LN, Zeuthen LH, Christensen HR et al (2007) Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int Immunol 19:1319\u20131327. https:\/\/doi.org\/10.1093\/intimm\/dxm103","journal-title":"Int Immunol"},{"key":"10807_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00576","volume":"6","author":"VT Bui","year":"2015","unstructured":"Bui VT, Tseng H-C, Kozlowska A et al (2015) Augmented IFN-\u03b3 and TNF-\u03b1 induced by probiotic bacteria in NK cells mediate differentiation of stem-like tumors leading to inhibition of tumor growth and reduction in inflammatory cytokine release; regulation by IL-10. Front Immunol 6:576. https:\/\/doi.org\/10.3389\/fimmu.2015.00576","journal-title":"Front Immunol"},{"key":"10807_CR197","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6566","volume":"348","author":"G Eberl","year":"2015","unstructured":"Eberl G, Colonna M, Santo JPD, McKenzie ANJ (2015) Innate lymphoid cells: a new paradigm in immunology. Science 348:aaa6566. https:\/\/doi.org\/10.1126\/science.aaa6566","journal-title":"Science"},{"key":"10807_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.03.003","volume":"41","author":"SK Panda","year":"2019","unstructured":"Panda SK, Colonna M (2019) Innate lymphoid cells: a potential link between microbiota and immune responses against cancer. Semin Immunol 41:101271. https:\/\/doi.org\/10.1016\/j.smim.2019.03.003","journal-title":"Semin Immunol"},{"key":"10807_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108937","volume":"110","author":"G Yin","year":"2022","unstructured":"Yin G, Zhao C, Pei W (2022) Crosstalk between macrophages and innate lymphoid cells (ILCs) in diseases. Int Immunopharmacol 110:108937. https:\/\/doi.org\/10.1016\/j.intimp.2022.108937","journal-title":"Int Immunopharmacol"},{"key":"10807_CR200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01235","volume":"10","author":"T Wang","year":"2019","unstructured":"Wang T, Zheng N, Luo Q et al (2019) Probiotics Lactobacillus reuteri abrogates immune checkpoint blockade-associated colitis by inhibiting group 3 innate lymphoid cells. Front Immunol 10:1235. https:\/\/doi.org\/10.3389\/fimmu.2019.01235","journal-title":"Front Immunol"},{"key":"10807_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21643-0","volume":"12","author":"J Hrd\u00fd","year":"2022","unstructured":"Hrd\u00fd J, Couturier-Maillard A, Boutillier D et al (2022) Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis. Sci Rep 12:17591. https:\/\/doi.org\/10.1038\/s41598-022-21643-0","journal-title":"Sci Rep"},{"key":"10807_CR202","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.32449","volume":"77","author":"C Hu","year":"2022","unstructured":"Hu C, Xu B, Wang X et al (2022) Gut microbiota\u2013derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatology 77:48\u201364. https:\/\/doi.org\/10.1002\/hep.32449","journal-title":"Hepatology"},{"key":"10807_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41950-y","volume":"14","author":"G Li","year":"2023","unstructured":"Li G, Liu L, Lu T (2023) Gut microbiota aggravates neutrophil extracellular traps-induced pancreatic injury in hypertriglyceridemic pancreatitis. Nat Commun 14:6179. https:\/\/doi.org\/10.1038\/s41467-023-41950-y","journal-title":"Nat Commun"},{"key":"10807_CR204","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ypmed.2004.07.019","volume":"40","author":"K Morimoto","year":"2005","unstructured":"Morimoto K, Takeshita T, Nanno M (2005) Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. Prev Med 40:589\u2013594. https:\/\/doi.org\/10.1016\/j.ypmed.2004.07.019","journal-title":"Prev Med"},{"key":"10807_CR205","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg5016","volume":"7","author":"ZA Rizvi","year":"2021","unstructured":"Rizvi ZA, Dalal R, Sadhu S et al (2021) High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci Adv 7:eabg5016. https:\/\/doi.org\/10.1126\/sciadv.abg5016","journal-title":"Sci Adv"},{"key":"10807_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00549-9","volume":"6","author":"C Kong","year":"2021","unstructured":"Kong C, Yan X, Liu Y et al (2021) Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome. Signal Transduct Target Ther 6:154. https:\/\/doi.org\/10.1038\/s41392-021-00549-9","journal-title":"Signal Transduct Target Ther"},{"key":"10807_CR207","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1469-0691.2012.03861.x","volume":"18","author":"LW Parfrey","year":"2012","unstructured":"Parfrey LW, Knight R (2012) Spatial and temporal variability of the human microbiota. Clin Microbiol Infect 18:8\u201311. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03861.x","journal-title":"Clin Microbiol Infect"},{"key":"10807_CR208","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01310-22","volume":"10","author":"W Zhang","year":"2022","unstructured":"Zhang W, Han N, Zhang T et al (2022) The spatial features and temporal changes in the gut microbiota of a healthy Chinese population. Microbiol Spectr 10:e01310\u201322. https:\/\/doi.org\/10.1128\/spectrum.01310-22","journal-title":"Microbiol Spectr"},{"key":"10807_CR209","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000444066","volume":"93","author":"A Andoh","year":"2016","unstructured":"Andoh A (2016) Physiological role of gut microbiota for maintaining human health. Digestion 93:176\u2013181. https:\/\/doi.org\/10.1159\/000444066","journal-title":"Digestion"},{"key":"10807_CR210","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1113\/ep090226","volume":"107","author":"E Shehata","year":"2022","unstructured":"Shehata E, Parker A, Suzuki T et al (2022) Microbiomes in physiology: insights into 21st-century global medical challenges. Exp Physiol 107:257\u2013264. https:\/\/doi.org\/10.1113\/ep090226","journal-title":"Exp Physiol"},{"key":"10807_CR211","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.969524","volume":"13","author":"Q Gao","year":"2022","unstructured":"Gao Q, Sun G, Duan J et al (2022) Alterations in gut microbiota improve SCFA production and fiber utilization in Tibetan pigs fed alfalfa diet. Front Microbiol 13:969524. https:\/\/doi.org\/10.3389\/fmicb.2022.969524","journal-title":"Front Microbiol"},{"key":"10807_CR212","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ (2017) Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 19:29\u201341. https:\/\/doi.org\/10.1111\/1462-2920.13589","journal-title":"Environ Microbiol"},{"key":"10807_CR213","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-022-02825-5","volume":"79","author":"CT Peterson","year":"2022","unstructured":"Peterson CT, Santiago JP, Iablokov SN et al (2022) Short-chain fatty acids modulate healthy gut microbiota composition and functional potential. Curr Microbiol 79:128. https:\/\/doi.org\/10.1007\/s00284-022-02825-5","journal-title":"Curr Microbiol"},{"key":"10807_CR214","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01454-19","volume":"10","author":"MA Sze","year":"2019","unstructured":"Sze MA, Top\u00e7uo\u011flu BD, Lesniak NA (2019) Fecal short-chain fatty acids are not predictive of colonic tumor status and cannot be predicted based on bacterial community structure. MBio 10:e01454\u201319. https:\/\/doi.org\/10.1128\/mbio.01454-19","journal-title":"MBio"},{"key":"10807_CR215","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7:189\u2013200. https:\/\/doi.org\/10.1080\/19490976.2015.1134082","journal-title":"Gut Microbes"},{"key":"10807_CR216","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00886-20","volume":"11","author":"EC Soto-Martin","year":"2020","unstructured":"Soto-Martin EC, Warnke I, Farquharson FM et al (2020) Vitamin biosynthesis by human gut butyrate-producing bacteria and cross-feeding in synthetic microbial communities. mBio 11:e00886-20. https:\/\/doi.org\/10.1128\/mbio.00886-20","journal-title":"mBio"},{"key":"10807_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122862","volume":"11","author":"ER Leeming","year":"2019","unstructured":"Leeming ER, Johnson AJ, Spector TD, Roy CIL (2019) Effect of diet on the gut microbiota: rethinking intervention duration. Nutrients 11:2862. https:\/\/doi.org\/10.3390\/nu11122862","journal-title":"Nutrients"},{"key":"10807_CR218","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559\u2013563. https:\/\/doi.org\/10.1038\/nature12820","journal-title":"Nature"},{"key":"10807_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2023.111980","volume":"110","author":"M Cassotta","year":"2023","unstructured":"Cassotta M, Cianciosi D, Giuseppe RD (2023) Possible role of nutrition in the prevention of inflammatory bowel disease\u2013related colorectal cancer: a focus on human studies. Nutrition 110:111980. https:\/\/doi.org\/10.1016\/j.nut.2023.111980","journal-title":"Nutrition"},{"key":"10807_CR220","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cgh.2020.01.046","volume":"18","author":"A Levine","year":"2020","unstructured":"Levine A, Rhodes JM, Lindsay JO et al (2020) Dietary guidance from the international organization for the study of inflammatory bowel diseases. Clin Gastroenterol Hepatol 18:1381\u20131392. https:\/\/doi.org\/10.1016\/j.cgh.2020.01.046","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10807_CR221","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00583-21","volume":"90","author":"A Maldonado-Contreras","year":"2022","unstructured":"Maldonado-Contreras A (2022) Food as treatment of inflammatory bowel diseases. Infect Immun 90:e00583\u201321. https:\/\/doi.org\/10.1128\/iai.00583-21","journal-title":"Infect Immun"},{"key":"10807_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-1099-8","volume":"16","author":"HS Al-Salem","year":"2016","unstructured":"Al-Salem HS, Bhat RS, Al-Ayadhi L, El-Ansary A (2016) Therapeutic potency of bee pollen against biochemical autistic features induced through acute and sub-acute neurotoxicity of orally administered propionic acid. BMC Complement Altern Med 16:120. https:\/\/doi.org\/10.1186\/s12906-016-1099-8","journal-title":"BMC Complement Altern Med"},{"key":"10807_CR223","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/lipd.12005","volume":"53","author":"H Yu","year":"2018","unstructured":"Yu H, Li R, Huang H et al (2018) Short-chain fatty acids enhance the lipid accumulation of 3T3-L1 cells by modulating the expression of enzymes of fatty acid metabolism. Lipids 53:77\u201384. https:\/\/doi.org\/10.1002\/lipd.12005","journal-title":"Lipids"},{"key":"10807_CR224","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cels.2020.02.008","volume":"10","author":"M Trapecar","year":"2020","unstructured":"Trapecar M, Communal C, Velazquez J et al (2020) Gut-liver physiomimetics reveal paradoxical modulation of IBD-related inflammation by short-chain fatty acids. Cell Syst 10:223-239.e9. https:\/\/doi.org\/10.1016\/j.cels.2020.02.008","journal-title":"Cell Syst"},{"key":"10807_CR225","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/ajcn\/nqac085","volume":"116","author":"A Cherta-Murillo","year":"2022","unstructured":"Cherta-Murillo A, Pugh JE, Alaraj-Alshehhi S et al (2022) The effects of SCFAs on glycemic control in humans: a systematic review and meta-analysis. Am J Clin Nutr 116:335\u2013361. https:\/\/doi.org\/10.1093\/ajcn\/nqac085","journal-title":"Am J Clin Nutr"},{"key":"10807_CR226","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0485-7","volume":"16","author":"A El-Ansary","year":"2017","unstructured":"El-Ansary A, Al-Salem HS, Asma A, Al-Dbass A (2017) Glutamate excitotoxicity induced by orally administered propionic acid, a short chain fatty acid can be ameliorated by bee pollen. Lipids Health Dis 16:96. https:\/\/doi.org\/10.1186\/s12944-017-0485-7","journal-title":"Lipids Health Dis"},{"key":"10807_CR227","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122913","volume":"11","author":"MP Dore","year":"2019","unstructured":"Dore MP, Bibb\u00f2 S, Fresi G (2019) Side effects associated with probiotic use in adult patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Nutrients 11:2913. https:\/\/doi.org\/10.3390\/nu11122913","journal-title":"Nutrients"},{"key":"10807_CR228","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/jcm.36.1.325-326.1998","volume":"36","author":"MR Oggioni","year":"1998","unstructured":"Oggioni MR, Pozzi G, Valensin PE et al (1998) Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 36:325\u2013326. https:\/\/doi.org\/10.1128\/jcm.36.1.325-326.1998","journal-title":"J Clin Microbiol"},{"key":"10807_CR229","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00134-002-1267-9","volume":"28","author":"T Lherm","year":"2002","unstructured":"Lherm T, Monet C, Nougi\u00e8re B et al (2002) Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 28:797\u2013801. https:\/\/doi.org\/10.1007\/s00134-002-1267-9","journal-title":"Intensive Care Med"},{"key":"10807_CR230","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/s0140-6736(08)60207-x","volume":"371","author":"MG Besselink","year":"2008","unstructured":"Besselink MG, van Santvoort HC, Buskens E et al (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651\u2013659. https:\/\/doi.org\/10.1016\/s0140-6736(08)60207-x","journal-title":"Lancet"},{"key":"10807_CR231","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1093\/cid\/civ085","volume":"60","author":"S Doron","year":"2015","unstructured":"Doron S, Snydman DR (2015) Risk and safety of probiotics. Clin Infect Dis 60:S129\u2013S134. https:\/\/doi.org\/10.1093\/cid\/civ085","journal-title":"Clin Infect Dis"},{"key":"10807_CR232","doi-asserted-by":"publisher","first-page":"74","DOI":"10.15403\/jgld-3936","volume":"31","author":"A Lorentz","year":"2022","unstructured":"Lorentz A, M\u00fcller L (2022) Probiotics in the treatment of inflammatory bowel disease in adulthood: a systematic review. J Gastrointest Liver Dis 31:74\u201384. https:\/\/doi.org\/10.15403\/jgld-3936","journal-title":"J Gastrointest Liver Dis"},{"key":"10807_CR233","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/ecco-jcc\/jjv203","volume":"10","author":"S Vermeire","year":"2016","unstructured":"Vermeire S, Joossens M, Verbeke K et al (2016) Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis 10:387\u2013394. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv203","journal-title":"J Crohns Colitis"},{"key":"10807_CR234","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ajg.2014.133","volume":"109","author":"CR Kelly","year":"2014","unstructured":"Kelly CR, Ihunnah C, Fischer M et al (2014) Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 109:1065\u20131071. https:\/\/doi.org\/10.1038\/ajg.2014.133","journal-title":"Am J Gastroenterol"},{"key":"10807_CR235","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/1751-7915.14074","volume":"15","author":"G Lu","year":"2022","unstructured":"Lu G, Wang W, Li P et al (2022) Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Microb Biotechnol 15:2439\u20132449. https:\/\/doi.org\/10.1111\/1751-7915.14074","journal-title":"Microb Biotechnol"},{"key":"10807_CR236","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3748\/wjg.v30.i11.1572","volume":"30","author":"S-J Chen","year":"2024","unstructured":"Chen S-J, Zhang D-Y, Wu X et al (2024) Washed microbiota transplantation for Crohn\u2019s disease: a metagenomic, metatranscriptomic, and metabolomic-based study. World J Gastroenterol 30:1572\u20131587. https:\/\/doi.org\/10.3748\/wjg.v30.i11.1572","journal-title":"World J Gastroenterol"},{"key":"10807_CR237","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/03007995.2022.2030563","volume":"38","author":"Y Wang","year":"2022","unstructured":"Wang Y, Cui B, Zhang F (2022) Refractory ulcerative colitis stabilized by interval washed microbiota transplantation: less is more. Curr Med Res Opin 38:531\u2013534. https:\/\/doi.org\/10.1080\/03007995.2022.2030563","journal-title":"Curr Med Res Opin"},{"key":"10807_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02929-7","volume":"23","author":"L Wu","year":"2023","unstructured":"Wu L, Yuan Q, Wu L et al (2023) Efficacy of washed microbiota transplantation for therapeutic targets of refractory functional constipation and the influencing factors: a single-center, retrospective, 24-week follow-up study. BMC Gastroenterol 23:291. https:\/\/doi.org\/10.1186\/s12876-023-02929-7","journal-title":"BMC Gastroenterol"},{"key":"10807_CR239","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1097\/mib.0b013e31829ea325","volume":"19","author":"PK Kump","year":"2013","unstructured":"Kump PK, Gr\u00f6chenig H-P, Lackner S et al (2013) Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 19:2155\u20132165. https:\/\/doi.org\/10.1097\/mib.0b013e31829ea325","journal-title":"Inflamm Bowel Dis"},{"key":"10807_CR240","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen NG, Fuentes S, van der Spek MJ et al (2015) Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149:110-118.e4. https:\/\/doi.org\/10.1053\/j.gastro.2015.03.045","journal-title":"Gastroenterology"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10807-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10807-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10807-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:02:21Z","timestamp":1778792541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10807-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":240,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10807"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10807-9","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}